Products and Care

Product Web Sites

CPSIA 155x50

As required by the Consumer Product Safety Improvement Act 2008, certifications for Schering-Plough products sold in child-resistant packaging can be found by clicking the link below:

Commitment to Care

The Commitment to Care program is designed to ensure that eligible individuals, including Medicare beneficiaries who meet our criteria, have access to Schering-Plough's cancer and hepatitis drugs. These medicines include:

  • PEGINTRON (peginterferon alfa-2b) Powder for Injection

  • REBETOL (ribavirin, USP) Capsules

  • INTRON A (Interferon alfa-2b, recombinant) for Injection

  • TEMODAR (temozolomide) Capsules

  • TICE BCG, BCG LIVE (for intravesical use)

  • NOXAFIL (posaconazole) Oral Suspension

The Commitment to Care program's reimbursement specialists provide eligible patients with all aspects of reimbursement assistance at no cost, including:

  • insurance verification,

  • pre-authorization or pre-certification,

  • denial appeals, and

  • referrals to state and local assistance programs.

In addition, the program distributed pharmaceutical products free of charge to more than 6,700 needy patients in 2008.

Unlike many other reimbursement programs, Commitment to Care is telephone based, offers patients easy access to a reimbursement assistance specialist with rapid follow up, and eliminates extensive paperwork.

To find out more about the Commitment to Care program, call toll free: 1-800-521-7157.